Colorectal Cancer News and Research

Latest Colorectal Cancer News and Research

Cleveland Biolabs Subsidiary Awarded $4.6M Russian Contract

...

23 Oct 2013

Pancreatic cancer patients may benefit from antibody-drug conjugates

Patients with pancreatic cancer may benefit from an investigational member of an emerging class of anticancer drugs called antibody-drug conjugates, according to preclinical results presented here at the AACR-NCI-EORTC International Conference on Molecular Targets and Cancer Therapeutics, held Oct. 19-23.

22 Oct 2013

Regeneron announces topline results from Phase 3 study of EYLEA Injection in patients with Macular Edema following BRVO

Regeneron Pharmaceuticals, Inc. today announced positive topline results for EYLEA® (aflibercept) Injection from the Phase 3 VIBRANT study in patients with Macular Edema following Branch Retinal Vein Occlusion (BRVO).

21 Oct 2013

New investigational drug offers potential treatment option for lung cancer

PF-06463922, an investigational drug being developed by Pfizer Inc., has the potential to become a new treatment option for patients who have lung cancer harboring abnormalities in the ALK gene, according to preclinical results presented here at the AACR-NCI-EORTC International Conference on Molecular Targets and Cancer Therapeutics, held Oct. 19-23.

21 Oct 2013

Study finds no relevant association between Vitamin D serum level and incidence of kidney stones

Increased vitamin D levels may prevent a wide range of diseases, according to recent studies. However, some previous studies led to a concern that vitamin D supplementation could increase an individual's risk of developing kidney stones.

18 Oct 2013

Simple urine test uses nanotechnology to detect dangerous blood clotting

Life-threatening blood clots can form in anyone who sits on a plane for a long time, is confined to bed while recovering from surgery, or takes certain medications.

17 Oct 2013

Phase 3 ODYSSEY MONO trial with alirocumab meets primary efficacy endpoint

Sanofi and Regeneron Pharmaceuticals, Inc. today announced that the Phase 3 ODYSSEY MONO trial with alirocumab, an investigational monoclonal antibody targeting PCSK9 (proprotein convertase subtilisin/kexin type 9), met its primary efficacy endpoint.

16 Oct 2013

immatics biotechnologies closes €34 million Series D financing round

immatics biotechnologies GmbH, a clinical-stage biopharmaceutical company developing advanced multi-peptide cancer vaccines that are active against cancer, today announced that it has closed a €34 million Series D financing round.

15 Oct 2013

Study evaluates economic cost of cancer across 27 countries of the EU

The first ever study to evaluate the economic cost of cancer across the 27 countries of the EU has found that the total cost of cancer in the EU in 2009 was €126 billion, with cancer in Germany, France, Italy, and the UK together accounting for just over two-thirds of this cost (€83 billion).

15 Oct 2013

NUS, A*STAR establish joint center to study role of nutrition and development in health, disease in Asia

The National University of Singapore (NUS) and A*STAR will be jointly establishing the S$148 million Singapore Centre for Nutritional Sciences, Metabolic Diseases, and Human Development (SiNMeD).

11 Oct 2013

Clinical Genomics Nabs Enterix, Aims To Launch New Bowel Cancer Blood Test

...

8 Oct 2013

Renowned leaders in diabetes prevention, treatment, research to descend at Jefferson Symposium

Renowned national and international leaders in diabetes prevention, treatment and research will descend on Philadelphia for the Second Annual Diabetes Symposium: New Advances and Innovations, a one-day symposium on advancing patient care at the intersection of diabetes and cardiovascular disease, cancer, sexual health and new this year, physicians and diabetes educators will address the latest advances in managing obesity in the diabetic patient.

7 Oct 2013

Designer Baby Patent Awarded To 23Andme

...

4 Oct 2013

Researchers discover how aspirin improves survival in patients diagnosed with colon cancer

Researchers believe they have discovered how aspirin improves survival in patients diagnosed with colon cancer, the 2013 European Cancer Congress (ECC2013) heard today.

1 Oct 2013

Study shows young patients are at highest risk of colorectal cancer progression, death

Younger patients with colorectal cancer that has spread to other parts of the body represent a high-risk group that is less likely to respond to treatment. Colorectal cancer in patients younger than 40 is more likely to grow despite treatment and young patients are at greater risk of death than people in other age groups.

1 Oct 2013

Researchers discover how aspirin improves survival in patients with colon cancer

Researchers believe they have discovered how aspirin improves survival in patients diagnosed with colon cancer, the 2013 European Cancer Congress heard today (Monday).

30 Sep 2013

Colorectal cancer in younger people appears to be more aggressive

Younger patients with colorectal cancer that has spread (metastasised) to other parts of the body represent a high-risk group that is less likely to respond to anti-cancer treatments.

29 Sep 2013

Colorectal cancer screening in European countries highly effective in reducing mortality

Screening for colorectal cancer in European countries is highly effective in reducing mortality from the disease. Some of the resources currently being devoted to breast and prostate screening programmes, where the evidence of effectiveness is much less clear-cut, should be reallocated to the early detection of CRC, the 2013 European Cancer Congress will hear today (Sunday).

29 Sep 2013

White paper addresses needs, challenges and solutions for improving mCRC treatment

The Angiogenesis Foundation released a white paper at the 2013 European Cancer Congress that addresses the needs, challenges, and proposed solutions for improving treatment of metastatic colorectal cancer, the third most common cancer among men and the second most common among women worldwide.

28 Sep 2013

Amgen Plans R&D Center In China

...

25 Sep 2013

Colorectal Cancer News and Research

Latest Colorectal Cancer News and Research

Cleveland Biolabs Subsidiary Awarded $4.6M Russian Contract

Pancreatic cancer patients may benefit from antibody-drug conjugates

Regeneron announces topline results from Phase 3 study of EYLEA Injection in patients with Macular Edema following BRVO

New investigational drug offers potential treatment option for lung cancer

Study finds no relevant association between Vitamin D serum level and incidence of kidney stones

Simple urine test uses nanotechnology to detect dangerous blood clotting

Phase 3 ODYSSEY MONO trial with alirocumab meets primary efficacy endpoint

immatics biotechnologies closes €34 million Series D financing round

Study evaluates economic cost of cancer across 27 countries of the EU

NUS, A*STAR establish joint center to study role of nutrition and development in health, disease in Asia

Clinical Genomics Nabs Enterix, Aims To Launch New Bowel Cancer Blood Test

Renowned leaders in diabetes prevention, treatment, research to descend at Jefferson Symposium

Designer Baby Patent Awarded To 23Andme

Researchers discover how aspirin improves survival in patients diagnosed with colon cancer

Study shows young patients are at highest risk of colorectal cancer progression, death

Researchers discover how aspirin improves survival in patients with colon cancer

Colorectal cancer in younger people appears to be more aggressive

Colorectal cancer screening in European countries highly effective in reducing mortality

White paper addresses needs, challenges and solutions for improving mCRC treatment

Amgen Plans R&D Center In China

Industry Focus - Oncology (1st Edition) eBook

How the Vutara VXL simplifies single-molecule imaging

How cohesin mechanics and nanotracker tech are redefining DNA research

Todd Bauman and Chris Povich

Colorectal Cancer News and Research

Latest Colorectal Cancer News and Research

Industry Focus - Oncology (1st Edition) eBook

How the Vutara VXL simplifies single-molecule imaging

How cohesin mechanics and nanotracker tech are redefining DNA research

Todd Bauman and Chris Povich

Newsletters you may be interested in